December 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreDecember 30, 2025
According to market projections, the global over-the-counter or OTC drugs market, valued at USD 142.27 billion in 2025, is anticipated to reach USD 268.32 billion by 2035, growing at a CAGR of 6.55% over the next decade. In 2024, North America led the OTC drugs market, while Asia-Pacific is set for rapid growth. Cough & cold products dominated,...
December 30, 2025
According to market projections, the GLP-1 drugs sector is expected to grow from USD 52.95 billion in 2025 to USD 132.79 billion by 2035, reflecting a CAGR of 9.63%. The GLP-1 drugs market is expanding due to increasing incidences of type 2 diabetes as well as growing GLP-1 drug applications. North America led the market due to a rise in obesity an...
December 30, 2025
Based on market forecasts, the global medical disposable positioning products market, projected at USD 1.13 billion in 2025, is expected to reach USD 2.17 billion by 2035, growing at a CAGR of 6.75% over the forecast period. Rising surgical and diagnostic procedure volumes worldwide increase the need for sterile and reliable patient positioning sol...
December 30, 2025
Market insights predict the global bone & joint health supplements industry will increase from USD 15.01 billion in 2025 to USD 34.04 billion by 2035, achieving a CAGR of 8.54%. The bone & joint health supplements market is growing due to rising osteoporosis cases. North America is leading the way due to rising arthritis cases....
December 30, 2025
According to market projections, the global head & neck cancer therapeutics market, valued at USD 2.65 billion in 2025, is anticipated to reach USD 8.14 billion by 2035, growing at a CAGR of 11.87% over the next decade. A surge in tobacco and alcohol consumption and the rising cases of HPV are impacting the global expansion. North America regis...
December 30, 2025
According to forecasts, the global antithrombin market will grow from USD 420.33 million in 2025 to USD 640.37 million by 2035, with an expected CAGR of 4.3%. The antithrombin market is driven by technological advancements across the various steps involved in its production. North America is leading the market due to the strong presence of the phar...
December 30, 2025
According to forecasts, the global hemorrhoids treatment market will grow from USD 1.21 billion in 2025 to USD 2.18 billion by 2035, with an expected CAGR of 6.05%. The rising incidence of hemorrhoids and the increasing minimally invasive procedures drive the market. North America dominated the global market due to a robust healthcare infrastructur...
December 29, 2025
Based on market forecasts, the global fondaparinux market, projected at USD 721 million in 2025, is expected to reach USD 1419.61 million by 2035, growing at a CAGR of 6.36% over the forecast period. The increasing number of surgeries and growing research activities drive the global market. North America dominated the global market owing to the pre...
December 29, 2025
Market insights predict the global sciatica treatment industry will increase from USD 796 million in 2025 to USD 1171.76 million by 2035, achieving a CAGR of 3.94%. The market is driven by sedentary lifestyles and aging populations, fuel demand for effective pain management solutions. North America is leading the global market, driven by robust hea...
December 29, 2025
According to market projections, the cardiometabolic diseases market was valued at USD 292.04 billion in 2026 and is projected to reach approximately USD 1,987.69 billion by 2035, growing at a strong CAGR of 23.75% from 2026 to 2035. The cardiometabolic diseases market analysis covers detailed segment data by disease type, therapeutic class, treatm...